File(s) under permanent embargo
Mobile technology for primary stroke prevention
Methods: A parallel, open-label, 2-arm prospective, proof-of-concept pilot randomized controlled trial. Participants were randomized to usual care/control or App intervention group and assessed at baseline, 3, and 6 months. The App measures stroke risk and provides information on management of risk factors. Participants were aged >19 years with at least 2 modifiable stroke risk factors identified, no prior stroke, and owned a smartphone.
Results: Fifty participants (24 control, 26 App) were recruited from 148 eligible participants. Retention in the trial was 87%. Mean cardiovascular health (Life's Simple 7) improved by 0.36 (95% CI, -2.10 to 1.38) in the App group compared with 0.01 (95% CI, -1.34 to 1.32) in controls ( P=0.6733).
Conclusions: These findings support a full randomized controlled trial to test the effectiveness of the Stroke Riskometer for primary stroke prevention.
History
Publication title
StrokeVolume
50Pagination
1-3ISSN
0039-2499Department/School
Menzies Institute for Medical ResearchPublisher
Lippincott Williams & WilkinsPlace of publication
530 Walnut St, Philadelphia, USA, Pa, 19106-3621Rights statement
© 2018 American Heart Association, Inc.Repository Status
- Restricted